Bolivia, Plurinational State of vs Korea: Tuberculosis treatment success rate
Bolivia, Plurinational State of
79.0%
in 2023
Korea
79.0%
in 2023
Bolivia, Plurinational State of rank
126th
Korea rank
126th
Tuberculosis treatment success rate over time
- Bolivia, Plurinational State of
- Korea
How they compare
Bolivia, Plurinational State of currently reports 79.0% against 79.0% in Korea, a difference of 0.0%.
The two have swapped places 8 times across 29 shared years of data; in 1994 it was Korea ahead.
Bolivia, Plurinational State of ranks 126th and Korea ranks 126th of 206 countries.
Across the 4 decades both report, Bolivia, Plurinational State of averaged higher in 1 and Korea in 3.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Korea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 70.0% | 76.4% | 6.4% | Korea |
| 2000s | 79.6% | 82.3% | 2.7% | Korea |
| 2010s | 83.7% | 83.3% | 0.4% | Bolivia, Plurinational State of |
| 2020s | 79.5% | 79.8% | 0.2% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Bolivia, Plurinational State of or Korea?
- Bolivia, Plurinational State of, at 79.0% against 79.0% in Korea as of 2023.
- What is the difference in tuberculosis treatment success rate between Bolivia, Plurinational State of and Korea?
- 0.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Korea?
- 29 years are reported by both, from 1994 to 2023.
- How do Bolivia, Plurinational State of and Korea rank globally for tuberculosis treatment success rate?
- Bolivia, Plurinational State of ranks 126th and Korea ranks 126th of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.